Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Pilot Study of BB3 to Improve Renal Function in Patients With Signs and Symptoms of Significant Renal Injury After Kidney Transplantation and at Risk for Dialysis

NCT01286727 is registered in ClinicalTrials.gov with Angion Biomedica Corp as lead sponsor.

NCT NCT01286727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01286727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Pilot Study of BB3 to Improve Renal Function in Patients With Signs and Symptoms of Significant Renal Injury After Kidney Transplantation and at Risk for Dialysis
Lead sponsor
Angion Biomedica Corp
Phase
Phase 2
Overall status
Unknown status
Start date
February 28, 2010
Completion date
February 29, 2016
Enrollment
30 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

delayed graft function